4D Molecular Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of FDMT for the last quarter is 20.20 M USD, and it's 8353.56% higher compared to the previous quarter. The net income of Q3 23 is -10.26 M USD.